S&P 500
1637.59
-14.22 -0.86%
Dow Indu
15181.07
-137.16 -0.90%
Nasdaq
3456.40
-25.78 -0.74%
Crude Oil
98.08
-0.59 -0.60%
Gold
1372.870
+6.540 +0.48%
Euro
1.33360
-0.00550 -0.41%
US Dollar
81.349
+0.662 +0.85%
Weak

2 YEAR T-NOTES Sep 2013 (E) Future

Chicago Board of Trade2 YEAR T-NOTES Sep 2013 (E) (CBOT:ZT.U13.E)

110.093750 -0.085938 (-0.08%)

2013-06-19 15:03:45, 10 min delay

2 YEAR T-NOTES Sep 2013 (E) (CBOT:ZT.U13.E) $metamarket Chart
1 Day
3 Day
5 Day
1 Month
3 Month
6 Month
1 Year
Max
Last Price110.093750
Open110.171875
High110.195313
Volume144,608
Time2013-06-19 15:03:45
Contract High Date2013-05-01
Contract Low Date2013-06-11
First Delivery2013-10-03
Open Time18:00
Settle Time17:15
Previous Close110.171875
Low110.070313
Open Int.764352
Contract High110.328125
Contract Low110
Estimated Volume34598
Expiration2013-09-30
Close Time17:00

Today's Top 50 Trending Stocks: Let our SmartScan and Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly rank today's top 50 stocks for you. This complimentary list will update throughout the day to highlight the most timely trading opportunities.

First Name
Last Name
Email
 
By filling out the form, you'll receive instant access to Today's Top 50 Trending Stocks list and other trading resources from INO.com.

List of Top Stocks


Trader's Blog

Today's Video Update: To Taper Or Not To Taper? 1 hour, 25 minutes ago
Stocks edge lower as investors wait on Fed 2 hours, 26 minutes ago
Crude Oil Breakout & Some Implications 5 hours ago
Fundamentals Can Kill You If You're Not Careful! 23 hours ago

Today's News

Keryx shares rise on analyst's Zerenex forecast

1 hour, 26 minutes ago

Shares of Keryx Biopharmaceuticals Inc. rose Wednesday after a JPMorgan analyst started covering the stock with an "Overweight" rating and a positive view on the company's experimental drug Zerenex. THE BIG PICTURE: Keryx has no approved drugs and Zerenex is its only product in clinical testing. The company is preparing to file for marketing approval of the drug as a treatment for hyperphosphatemia in dialysis patients with chronic kidney disease.

Pruitt: DOJ broke rules in phone records seizure

1 hour, 26 minutes ago

The Justice Department violated its own rules when it secretly seized records for thousands of phone calls to and from journalists for The Associated Press as part of a leak investigation, the head of the company said Wednesday. The freedom of the press, Pruitt said, is a bedrock of the U.S. Constitution and the sweeping seizure of phone records threatens the very foundation of that freedom. "The DOJ's actions could not have been more tailor-made to comfort authoritarian regimes that want to suppress their own news media," he said.

Diverted United 787 passengers on way to Tokyo

1 hour, 30 minutes ago

Passengers from a United Airlines Denver-to-Tokyo flight that diverted to Seattle Tuesday when the Boeing 787 had an oil filter issue are on their way again. A Boeing spokeswoman told The Seattle Times Tuesday the problem was unrelated to any battery issues that grounded the 787 fleet from January to May.

Brand rankings in 2013 quality survey

1 hour, 30 minutes ago

J.D. Power and Associates released its ranking of initial quality in 2013 model-year vehicles Wednesday. Here's how the brands stacked up, along with their problems per 100 vehicles and how much they moved up or down in the rankings from last year. 1. Porsche (80, +2) 2. GMC (90, +10) 3. Lexus (94, -2)

INO.com on Facebook INO.com MarketClub on Twitter INO.com YouTube

© Copyright INO.com, Inc. All Rights Reserved.